Literature DB >> 11847146

Mechanical reperfusion therapy for acute myocardial infarction: Stent PAMI, ADMIRAL, CADILLAC and beyond.

B R Brodie, T D Stuckey.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2002        PMID： 11847146      PMCID： PMC1767020          DOI： 10.1136/heart.87.3.191

Source DB:  PubMed          Journal:  Heart        ISSN： 1355-6037            Impact factor:   5.994


× No keyword cloud information.
  9 in total

1.  Platelet glycoprotein IIb/IIIa inhibition with coronary stenting for acute myocardial infarction.

Authors:  G Montalescot; P Barragan; O Wittenberg; P Ecollan; S Elhadad; P Villain; J M Boulenc; M C Morice; L Maillard; M Pansiéri; R Choussat; P Pinton
Journal:  N Engl J Med       Date:  2001-06-21       Impact factor: 91.245

2.  Normal flow (TIMI-3) before mechanical reperfusion therapy is an independent determinant of survival in acute myocardial infarction: analysis from the primary angioplasty in myocardial infarction trials.

Authors:  G W Stone; D Cox; E Garcia; B R Brodie; M C Morice; J Griffin; L Mattos; A J Lansky; W W O'Neill; C L Grines
Journal:  Circulation       Date:  2001-08-07       Impact factor: 29.690

3.  Reperfusion therapy for acute myocardial infarction with fibrinolytic therapy or combination reduced fibrinolytic therapy and platelet glycoprotein IIb/IIIa inhibition: the GUSTO V randomised trial.

Authors:  E J Topol
Journal:  Lancet       Date:  2001-06-16       Impact factor: 79.321

4.  Clinical value of 12-lead electrocardiogram after successful reperfusion therapy for acute myocardial infarction. Zwolle Myocardial infarction Study Group.

Authors:  A W van 't Hof; A Liem; M J de Boer; F Zijlstra
Journal:  Lancet       Date:  1997-08-30       Impact factor: 79.321

5.  Facilitation of early percutaneous coronary intervention after reteplase with or without abciximab in acute myocardial infarction: results from the SPEED (GUSTO-4 Pilot) Trial.

Authors:  H C Herrmann; D J Moliterno; E M Ohman; A L Stebbins; C Bode; A Betriu; F Forycki; J S Miklin; W B Bachinsky; A M Lincoff; R M Califf; E J Topol
Journal:  J Am Coll Cardiol       Date:  2000-11-01       Impact factor: 24.094

6.  Benefit of coronary reperfusion before intervention on outcomes after primary angioplasty for acute myocardial infarction.

Authors:  B R Brodie; T D Stuckey; C Hansen; D Muncy
Journal:  Am J Cardiol       Date:  2000-01-01       Impact factor: 2.778

7.  Coronary angioplasty with or without stent implantation for acute myocardial infarction. Stent Primary Angioplasty in Myocardial Infarction Study Group.

Authors:  C L Grines; D A Cox; G W Stone; E Garcia; L A Mattos; A Giambartolomei; B R Brodie; O Madonna; M Eijgelshoven; A J Lansky; W W O'Neill; M C Morice
Journal:  N Engl J Med       Date:  1999-12-23       Impact factor: 91.245

8.  Importance of time to reperfusion for 30-day and late survival and recovery of left ventricular function after primary angioplasty for acute myocardial infarction.

Authors:  B R Brodie; T D Stuckey; T C Wall; G Kissling; C J Hansen; D B Muncy; R A Weintraub; T A Kelly
Journal:  J Am Coll Cardiol       Date:  1998-11       Impact factor: 24.094

9.  Effect of glycoprotein IIb/IIIa receptor blockade on recovery of coronary flow and left ventricular function after the placement of coronary-artery stents in acute myocardial infarction.

Authors:  F J Neumann; R Blasini; C Schmitt; E Alt; J Dirschinger; M Gawaz; A Kastrati; A Schömig
Journal:  Circulation       Date:  1998-12-15       Impact factor: 29.690
  9 in total
  1 in total

1.  Interaction between arrival time and thrombolytic treatment in determining early outcome of acute myocardial infarction.

Authors:  J Wilkinson; K Foo; N Sekhri; J Cooper; A Suliman; K Ranjadayalan; A D Timmis
Journal:  Heart       Date:  2002-12       Impact factor: 5.994
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.